INS and type 2 diabetes mellitus: In conclusion, this study confirmed that the use of isCGM could, due to its effectiveness and safety, be considered a useful tool for improving overall glycaemic control in patients with type 2 diabetes who are being treated with non-insulin or basal insulin therapy.